Custom CRISPR-Cas9 RNP service for simultaneous knockout of multiple target genes in Sf9, S2, and other insect cell lines.
We provide custom multi-gene knockout strain construction in insect cells using optimized CRISPR-Cas9 ribonucleoprotein (RNP) complexes. This service is designed for researchers requiring stable, heritable knockout of several genes in a single cell line, enabling complex pathway studies and recombinant protein production improvement.
We combine advanced sgRNA design, efficient Cas9 RNP delivery, and robust single-cell cloning to generate clean multi-gene knockout strains.
Custom sgRNAs are designed for each target gene using proprietary algorithms to minimize off-target effects and ensure high on-target cleavage. We prioritize exonic regions conserved across target isoforms.
Pre-assembled Cas9-sgRNA ribonucleoprotein complexes are delivered into insect cells via electroporation or lipid-based transfection, ensuring high editing efficiency and low cytotoxicity. Single cells are sorted into 96-well plates for clonal expansion.
We assist in selecting suitable target genes based on your research goals, considering essentiality, redundancy, and polyploidy in insect cells.
Our RNP delivery method typically yields high editing efficiency across multiple loci, reducing the number of clones needed to isolate desired multi-gene knockouts.
Knockout status is verified by PCR amplification of each target locus followed by Sanger sequencing. Indel analysis identifies predicted disruptive alleles; actual loss of function requires a suitable protein or functional readout.
Upon project completion, you will receive the following deliverables.
Each project is scoped based on your specific requirements. Below are typical parameters that can be customized.
| Parameter | Typical project scope |
|---|---|
| Target number of genes | Typically 1–5 genes; up to 8 genes evaluated on a case-by-case basis. |
| Insect cell line | Sf9, Sf21, High Five, S2, or other susceptible insect cells (confirmed by customer). |
| Guide RNA design strategy | Target-specific sgRNAs with in silico off-target analysis, prioritizing exonic regions conserved across target isoforms |
| Delivery method | Electroporation or lipofection; method optimized per cell line. |
| Clone screening depth | Number of clones screened and number of positive clones delivered (as scoped). |
| Validation method | Sanger sequencing of each target locus; optional off-target analysis by targeted amplicon sequencing (extra). |
| Quality control | Confirmation of knockout by PCR and sequencing; mycoplasma testing included. |
From gene targets to validated knockout clones, our streamlined workflow ensures efficient project execution.
We review your target gene list and insect cell line. Our bioinformatics team designs custom multiplexed sgRNAs for each gene, performing off-target prediction and prioritizing high-efficiency guides.
Synthesized sgRNAs are combined with recombinant Cas9 protein to form ready-to-deliver ribonucleoprotein complexes. Quality control includes gel electrophoresis and activity assays to support complex integrity.
RNP complexes are delivered into the target insect cells using optimized electroporation or lipid-based transfection protocols. Transfected cells are incubated to allow double-strand break repair and indel formation.
Edited cells are isolated into 96-well plates by single-cell FACS or limiting dilution. Clones are expanded under standard culture conditions until sufficient cell numbers for genotyping.
Genomic DNA from each clone is extracted. Each target locus is PCR-amplified and Sanger sequenced. Clones with biallelic or multi-allelic predicted disruptive edits at all target genes are advanced to deliverable status; functional loss requires an appropriate protein or activity readout.
Multi-gene knockout insect cell lines are used across diverse research and bioproduction areas.
Knockout of genes encoding proteases, glycosylation enzymes, or metabolic bottlenecks can be used to investigate effects on protein expression and product quality.
Simultaneous disruption of multiple genes in signaling or metabolic pathways enables systematic investigation of gene function and interaction.
Knockout of antiviral response genes or apoptosis pathway genes can increase viral vector and vaccine yields in insect cell platforms.
Common inquiries about our multi-gene knockout service in insect cells.
We routinely work with Sf9, Sf21, High Five (BTI-TN-5B1-4), and Drosophila S2 cells. Other cell lines can be evaluated upon request. The host cell line must be confirmed as suitable for CRISPR-Cas9 delivery and clonal expansion.
The number of target genes is project-dependent. We typically design for up to 5 genes in a single project. Higher multiplexing may be possible after consultation, but we recommend starting with 2–4 genes to balance editing efficiency and screening effort.
Each target locus is PCR-amplified and Sanger sequenced. We analyze the sequencing chromatograms for indels causing frameshifts or premature stop codons. For polyploid insect cells (e.g., Sf9), we evaluate the allelic disruption pattern to identify predicted disruptive genotypes; functional knockout requires an appropriate protein or activity readout. Optional western blot or functional assays can be added.
We perform in silico off-target prediction for all sgRNA designs using standard algorithms. If requested, targeted amplicon sequencing of top predicted off-target sites can be included as an optional QC step. However, genome-wide off-target detection (e.g., GUIDE-seq) is not routinely offered for insect cells due to lack of validated methods.
Project timeline is established at the start based on the number of target genes, cell line, and screening requirements. Timelines for single-gene and multi-gene knockout projects are confirmed during project scoping. Exact timelines are provided in the project proposal.
Get a customized quote for your Multi-Gene Knockout Strain Construction in Insect Cells project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.